A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease

NCT ID: NCT02641392

Last Updated: 2019-01-29

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE3

Total Enrollment

310 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-25

Study Completion Date

2018-01-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess long-term safety data of GED-0301 for a period of up to 208 weeks in adult subjects (i.e., ≥ 18 years of age) who participated in the core Phase 3 GED-0301-CD-002 and GED-0301-CD-003 studies and adolescent subjects (i.e., 12 to 17 years of age) who participated in the core Phase 3 GED-0301-CD-003 study. Although all subjects will receive active treatment, this study is double-blinded for the entire 208 weeks for the purpose of preserving the blind of the subject's treatment allocation in the initial, core Phase 3 GED-0301 study.

The GED-0301-CD-003 trial was not initiated; see detailed description.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a long-term active treatment study in patients with Crohn's disease (CD). Subjects who met the early escape criteria in Study GED-0301-CD-002, or subjects who completed Study GED-0301-002 or GED-0301-003, may be eligible for this study. Primary objective is to assess long-term safety of GED 0301. Additional efficacy and patient reported outcomes will be explored.

There are 5 possible treatment groups for GED-0301-CD-002 Subjects (Groups 1-5). There are 3 possible treatment groups for GED-0301-CD-003 subjects (Groups 1-3). Treatment is assigned based on clinical improvement achieved or not achieved from the core GED-0301 study.

1. continuous GED-0301 160 mg once daily for 12 weeks, followed by alternating placebo once daily for 4 weeks with GED-0301 160 mg once daily for 4 weeks, through Week 208;
2. alternating GED-0301 160 mg once daily for 4 weeks with placebo once daily for 4 weeks, through Week 208;
3. alternating placebo once daily for 4 weeks with GED-0301 160 mg once daily for 4 weeks, through Week 208;
4. continuous GED-0301 40 mg once daily through Week 208;
5. alternating placebo once daily for 4 weeks, followed by GED-0301 40 mg once daily for 4 weeks, through Week 208.

The GED-0301-CD-003 trial was not initiated; the GED-0301 program was terminated; no safety findings were noted.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Crohn's Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

GED-0301 (160 mg) followed by Placebo intermittent 160 mg

GED-0301 160 mg once daily (QD) for 12 weeks, followed by alternating Placebo (PBO) QD for 4 weeks with GED 0301 160 mg QD for 4 weeks, up to 208 weeks, if the subject previously received Placebo in the prior GED-0301 Study

Group Type EXPERIMENTAL

GED-0301

Intervention Type DRUG

Mongersen

Intermittent GED-0301 160 mg and placebo

Alternating GED-0301 160 mg once daily (QD) for 4 weeks with placebo (PBO) QD for 4 weeks, up to 208 weeks, depending on previous response in the prior GED-0301 study

Group Type EXPERIMENTAL

GED-0301

Intervention Type DRUG

Mongersen

Placebo

Intervention Type OTHER

Placebo

Intermittent placebo and GED-0301 40 mg

Alternating PBO once daily (QD) for 4 weeks with GED-0301 40 mg QD for 4 weeks with, up to 208 weeks, depending on previous response in the prior GED-0301 study

Group Type EXPERIMENTAL

GED-0301

Intervention Type DRUG

Mongersen

Placebo

Intervention Type OTHER

Placebo

Continuous GED-0301 40 mg

GED-0301 40 mg once daily (QD) for up to 208 weeks

Group Type EXPERIMENTAL

GED-0301

Intervention Type DRUG

Mongersen

Intermittent placebo and GED-0301 160 mg

Alternating PBO QD for 4 weeks with GED-0301 160 mg QD for 4 weeks, through Week 208

Group Type EXPERIMENTAL

GED-0301

Intervention Type DRUG

Mongersen

Placebo

Intervention Type OTHER

Placebo

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

GED-0301

Mongersen

Intervention Type DRUG

Placebo

Placebo

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Mongersen

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Subjects must satisfy the following criteria to be screened and enrolled in the study:

* Male or female ≥ 18 years of age.
* Subject must have participated in the GED-0301-CD-002 or GED 0301 CD 003 study.
* Subject must use protocol approved contraception.


Adolescent subjects must satisfy the following criteria to be screened and enrolled in the study

* Male or female 12 to 17 years of age.
* Subject must have participated in the GED 0301 CD 003 study.
* Subject is able to swallow the IP tablets.
* Subject must use protocol approved contraception.

Exclusion Criteria

The presence of any of the following will exclude a subject from screening and enrollment:

* Subject had experienced a serious adverse event (SAE) related to the investigational product while participating in the previous Phase 3 GED-0301 study.
* Subject has initiated biologic agents, such as TNF-α blockers or integrin antagonists.
* Subject is pregnant or breastfeeding.
* Subject has developed a known hypersensitivity to oligonucleotides, GED 0301 or any ingredient in the investigational product.
Minimum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Celgene

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guillermo Rossiter, MD

Role: STUDY_DIRECTOR

Celgene

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical Associates Research Group Inc.

San Diego, California, United States

Site Status

Atlanta Gastroenterology Associates, LLC

Atlanta, Georgia, United States

Site Status

Indiana University

Indianapolis, Indiana, United States

Site Status

Health Science Research Center, LLC

Pratt, Kansas, United States

Site Status

Via Christi Research a division of Via Christi Hospitals Wichita Inc

Wichita, Kansas, United States

Site Status

Gastroenterology Associates LLC

Baton Rouge, Louisiana, United States

Site Status

Metropolitan Gastroenterology

Chevy Chase, Maryland, United States

Site Status

Clinical Research Institute of Michigan, LLC

Chesterfield, Michigan, United States

Site Status

Gastroenterology Associates of Western Michigan PLC

Wyoming, Michigan, United States

Site Status

Ehrhardt Clinical Research LLC

Belton, Missouri, United States

Site Status

Columbia University Medical Center

New York, New York, United States

Site Status

Trial Management Associates LLC

Wilmington, North Carolina, United States

Site Status

ClinSearch LLC

Chattanooga, Tennessee, United States

Site Status

Texas Clinical Research Institute LLC

Arlington, Texas, United States

Site Status

Texas Digestive Disease Consultants - Dallas

Dallas, Texas, United States

Site Status

Texas Digestive Disease Consultants - Southlake

Flower Mound, Texas, United States

Site Status

University of Texas Health Science Center at Houston

Houston, Texas, United States

Site Status

Sagact Pllc

San Antonio, Texas, United States

Site Status

San Antonio Military Medical Center

San Antonio, Texas, United States

Site Status

Digestive Health Specialists of Tyler

Tyler, Texas, United States

Site Status

Virginia Mason Medical Center

Seattle, Washington, United States

Site Status

University of Washington School of Medicine

Seattle, Washington, United States

Site Status

The Vancouver Clinic

Vancouver, Washington, United States

Site Status

Concord Repatriation General Hospital

Concord, New South Wales, Australia

Site Status

Centre For Digestive Diseases

Five Dock, New South Wales, Australia

Site Status

Liverpool Hospital

Liverpool, New South Wales, Australia

Site Status

Mater Adult Hospital

South Brisbane, Queensland, Australia

Site Status

Royal Adelaide Hospital

Adelaide, South Australia, Australia

Site Status

Box Hill Hospital

Box Hill, Victoria, Australia

Site Status

The Alfred Hospital

Melbourne, Victoria, Australia

Site Status

Monash Medical Centre Clayton

Bentleigh East, , Australia

Site Status

LKH Universitaetsklinikum Graz

Graz, , Austria

Site Status

Medizinische Universitat Innsbruck

Innsbruck, , Austria

Site Status

KH der Barmherzigen Bruder Linz

Linz, , Austria

Site Status

LKH - Universitätsklinikum der PMU Salzburg

Salzburg, , Austria

Site Status

KH der Barmherzigen Brüder St.Veit an der Glan

Sankt Veit an der Glan, , Austria

Site Status

Krankenanstalt Rudolfstiftung Wien

Wein, , Austria

Site Status

AKH Medizinische Universitat Wien

Wein, , Austria

Site Status

Universitair Ziekenhuis Brussel

Brussels, , Belgium

Site Status

UZ Leuven

Leuven, , Belgium

Site Status

CHU Sart Tilman

Liège, , Belgium

Site Status

MHAT Kaspela EOOD

Plovdiv, , Bulgaria

Site Status

MHAT Ruse AD

Rousse, , Bulgaria

Site Status

Second MHAT Sofia AD

Sofia, , Bulgaria

Site Status

City Clinic UMHAC EOOD

Sofia, , Bulgaria

Site Status

UMHAT Sv Ivan Rilski EAD

Sofia, , Bulgaria

Site Status

UMHAT Tsaritsa Yoanna - ISUL EAD

Sofia, , Bulgaria

Site Status

MHAT Doverie AD

Sofia, , Bulgaria

Site Status

University of Calgary

Calgary, Alberta, Canada

Site Status

University of Alberta

Edmonton, Alberta, Canada

Site Status

South Edmonton Gastroenterology

Edmonton, Alberta, Canada

Site Status

Vancouver General Hospital

Vancouver, British Columbia, Canada

Site Status

GI Research Institute

Vancouver, British Columbia, Canada

Site Status

PerCuro Clinical Research

Victoria, British Columbia, Canada

Site Status

Brandon Medical Arts Clinic

Brandon, Manitoba, Canada

Site Status

McMaster University Health Sciences Center

Hamilton, Ontario, Canada

Site Status

London Health Science Center U. Hospital

London, Ontario, Canada

Site Status

LHSC Victoria Hospital

London, Ontario, Canada

Site Status

Montfort Hospital

Ottawa, Ontario, Canada

Site Status

Mount Sinai Hospital

Toronto, Ontario, Canada

Site Status

Toronto Digestive Disease Associates Inc

Vaughan, Ontario, Canada

Site Status

Medicine Professional Corporation

Waterloo, Ontario, Canada

Site Status

Centre de sante et de services sociaux Champlain Charles Le Moyne

Greenfield Park, Quebec, Canada

Site Status

McGill University Health Centre Glen Site Royal Victoria Hospital

Montreal, Quebec, Canada

Site Status

Clinical Hospital Centre Osijek

Osijek, , Croatia

Site Status

Fakultni nemocnice u sv Anny v Brne

Brno, , Czechia

Site Status

Hepato-Gastroenterologie HK

Hradec Králové, , Czechia

Site Status

PreventaMed

Olomouc, , Czechia

Site Status

CCBR Prague CZ

Prague, , Czechia

Site Status

Aarhus Universitetshospital

Aahus C, , Denmark

Site Status

Alborg Universitets Hospital

Aalborg, , Denmark

Site Status

Nordsjaellands Hospital Frederikssund

Frederikssund, , Denmark

Site Status

Herlev Hospital

Herlev, , Denmark

Site Status

Koge Sygehus

Køge, , Denmark

Site Status

Regionshospitalet Silkeborg

Silkeborg, , Denmark

Site Status

CHU Amiens Hopital Sud

Amiens, , France

Site Status

CHU Besancon Hopital Jean Minjoz

Besançon, , France

Site Status

CHU Tours Hopital Trousseau

Chambray-lès-Tours, , France

Site Status

CHU Clermont Ferrand

Clermont-Ferrand, , France

Site Status

Hopital Beaujon

Clichy, , France

Site Status

CHU Nantes Hotel Dieu

Nantes, , France

Site Status

CHU Nice Hopital de lArchet 2

Nice, , France

Site Status

Groupe Hospitalier Sud Hopital Haut Leveque USN

Pessac, , France

Site Status

Centre Hospitalier Lyon Sud

Pierre-Bénite, , France

Site Status

CHU Reims Hopital Robert Debre

Reims, , France

Site Status

CHU Rennes Hopital Pontchaillou

Rennes, , France

Site Status

CHU Saint Etienne Hopital Nord

Saint-Etienne, , France

Site Status

CHU Strasbourg Hopital Hautepierre

Strasbourg, , France

Site Status

CHU de Toulouse Hopital Rangueil

Toulouse, , France

Site Status

Hopital de Brabois Adultes

Vandœuvre-lès-Nancy, , France

Site Status

Charite Universitaetsmedizin Berlin Campus Benjamin Franklin

Berlin, , Germany

Site Status

DRK Kliniken Berlin Westend

Berlin, , Germany

Site Status

Krankenhaus Waldfriede e V

Berlin, , Germany

Site Status

Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH

Bochum, , Germany

Site Status

Universitaetsklinikum Carl Gustav Carus TU Dresden

Dresden, , Germany

Site Status

Universitaetsklinikum Erlangen

Erlangen, , Germany

Site Status

Kliniken Essen-Mitte

Essen, , Germany

Site Status

Agaplesion Markus Krankenhaus

Frankfurt, , Germany

Site Status

Universitaetsklinikum Halle Saale

Halle, , Germany

Site Status

Asklepios Klinik Hamburg

Hamburg, , Germany

Site Status

Medizinische Hochschule Hannover

Hanover, , Germany

Site Status

Universitaetsklinikum Heidelberg

Heidelberg, , Germany

Site Status

Praxis fuer Gastroenterologie Dr Ehehal Dr Helmstaedter

Heidelberg, , Germany

Site Status

Universitaetsklinikum Jena

Jena, , Germany

Site Status

Universitaetsklinikum Schleswig Holstein Campus Kiel

Kiel, , Germany

Site Status

University Leipzig

Leipzig, , Germany

Site Status

EUGASTRO GmbH

Leipzig, , Germany

Site Status

Medizinisches Zentrum Klinikum Lueneburg

Lüneburg, , Germany

Site Status

Klinikum Mannheim GmbH Universitaetsklinikum

Mannheim, , Germany

Site Status

Klinikum der Universitaet Muenchen

München, , Germany

Site Status

Gastro Campus Research

Münster, , Germany

Site Status

Staedtisches Klinikum Braunschweig gGmbH Standort Salzdahlumer

Niedersachsen, , Germany

Site Status

Universitaetsklinikum Regensburg

Regensburg, , Germany

Site Status

Universitaetsklinikum Ulm

Ulm, , Germany

Site Status

University General Hospital of Alexandroupolis

Alexandroupoli, , Greece

Site Status

General Hospital of Athens Evangelismos

Athens, , Greece

Site Status

Athens Medical Center

Athens, , Greece

Site Status

University General Hospital of Patras

Rio Patras, , Greece

Site Status

DRC Gyogyszervizsgalo Kozpont Kft

Balatonfüred, , Hungary

Site Status

Magyar Honvedseg Egeszsegugyi Kozpont

Budapest, , Hungary

Site Status

Semmelweis Egyetem AOK

Budapest, , Hungary

Site Status

Endomedix Diagnosztikai Kozpont

Budapest, , Hungary

Site Status

Debreceni Egyetem Klinikai Kozpont

Debrecen, , Hungary

Site Status

Szent Pantaleon Korhaz Rendelointezet Dunaujvaros

Dunaújváros, , Hungary

Site Status

Petz Aladar Megyei Oktato Korhaz

Győr, , Hungary

Site Status

Clinfan Szolgaltato Kft

Szekszárd, , Hungary

Site Status

HaEmek Medical Center

Afula, , Israel

Site Status

Soroka University Medical Center

Beersheba, , Israel

Site Status

Rambam Health Care Campus

Haifa, , Israel

Site Status

Shaare Zedek Medical Center

Jerusalem, , Israel

Site Status

Hadassah University Hospital

Jerusalem, , Israel

Site Status

Rabin Medical Center

Petah Tikva, , Israel

Site Status

Chaim Sheba Medical Center

Ramat Gan, , Israel

Site Status

Kaplan Medical Center

Rehovot, , Israel

Site Status

Tel Aviv Sourasky Medical Center Department of Hematology

Tel Aviv, , Israel

Site Status

The Baruch Padeh MC, Poriya

Tiberias, , Israel

Site Status

Assaf Harofeh Medical Center

Ẕerifin, , Israel

Site Status

Azienda Ospedaliera Universitaria Policlinico Sant Orsola Malpighi

Bologna, , Italy

Site Status

Azienda Ospedaliera Universitaria Policlinico G Martino

Messina, , Italy

Site Status

Fondazione IRCCS CA Granda Ospedale Maggiore Policlinico

Milan, , Italy

Site Status

Azienda Ospedaliera Vincenzo Cervello

Palermo, , Italy

Site Status

Fondazione IRCCS Policlinico San Matteo

Pavia, , Italy

Site Status

Universita Campus Bio Medico di Roma

Roma, , Italy

Site Status

Policlinico Universitario Agostino Gemelli

Roma, , Italy

Site Status

Azienda Ospedaliera San Camillo Forlanini

Rome, , Italy

Site Status

Azienda Ospedaliera Universitaria Policlinico Tor Vergata

Rome, , Italy

Site Status

Istituto Clinico Humanitas

Rozzano (MI), , Italy

Site Status

IRCCS Policlinico San Donato

San Donato Milanese, , Italy

Site Status

IRCCS Ospedale Casa Sollievo della Sofferenza

San Giovanni Rotondo FG, , Italy

Site Status

Digestive Diseases Center Gastro

Riga, , Latvia

Site Status

Pauls Stradins Clinical University Hospital

Riga, , Latvia

Site Status

VU Medisch Centrum

Amsterdam, , Netherlands

Site Status

Academisch Medisch Centrum

Amsterdam, , Netherlands

Site Status

Amphia Ziekenhuis

Breda, , Netherlands

Site Status

Radboudumc

Nijmegen, , Netherlands

Site Status

Zuyderland Medisch Centrum

Sittard-Geleen, , Netherlands

Site Status

St. Elisabeth Ziekenhuis

Tilburg, , Netherlands

Site Status

Akershus universitetssykehus HF

Lørenskog, , Norway

Site Status

Oslo Universitetssykehus Rikshospitalet

Oslo, , Norway

Site Status

Niepubliczny Zaklad Opieki Zdrowotnej POLIMEDICA

Kielce, , Poland

Site Status

Indywidualna Praktyka Lekarska Maciej Zymla

Knurów, , Poland

Site Status

SPZOZ Uniwersytecki Szpital Kliniczny im. Wojskowej Akademii Medycznej - Centralny Szpital Weteranow

Lodz, , Poland

Site Status

Centrum Medyczne Medyk

Rzeszów, , Poland

Site Status

Endoskopia Sp. z o.o.

Sopot, , Poland

Site Status

Hospital de Braga

Braga, , Portugal

Site Status

Hospital da Senhora da Oliveira Guimaraes

Guimarães, , Portugal

Site Status

S.C MedLife S.A

Bucharest, , Romania

Site Status

CMI Dr. Tirnaveanu Amelita

Oradea, , Romania

Site Status

Centrul de Gastroenterologie Dr. Goldis

Timișoara, , Romania

Site Status

TSBIH Territorial Clinical Hospital

Krasnoyarsk, , Russia

Site Status

SBHI of NN region RCH of NN n.a. N.A.Semashko

Nizhny Novgorod, , Russia

Site Status

SBEIHPE Novosibirsk State Medical University

Novosibirsk, , Russia

Site Status

FSBI Scientific Research Institute of Physyology and Basic Medicine under the SB of RAMS

Novosibirsk, , Russia

Site Status

Evromedservis

Pushkin, , Russia

Site Status

SEIHPE Rostov State Medical University of MoH of RF

Rostov-on-Don, , Russia

Site Status

SPb SBIH City Hospital # 26

Saint Petersburg, , Russia

Site Status

NonState Healthcare Institution Central Clinical Hospital, Samara station JSC Russian Railways

Samara, , Russia

Site Status

Clinical Center Zvezdara

Belgrade, , Serbia

Site Status

Military Medical Academy

Belgrade, , Serbia

Site Status

Clinical Center Bezanijska Kosa

Belgrade, , Serbia

Site Status

Fakultna nemocnica s poliklinikou F. D. Roosevelta

Banská Bystrica, , Slovakia

Site Status

Alian s.r.o.

Bardejov, , Slovakia

Site Status

Gastroeneterologicka ambulancia MUDr. Peter Hegyi s.r.o.

Malacky, , Slovakia

Site Status

Fakultna nemocnica Nitra

Nitra, , Slovakia

Site Status

KM Management, spol. s r.o.

Nitra, , Slovakia

Site Status

GASTRO I., s.r.o.

Prešov, , Slovakia

Site Status

Dong-A University Hospital

Busan, , South Korea

Site Status

Pusan National University Hospital

Busan, , South Korea

Site Status

Yeungnam University Medical Center

Daegu, , South Korea

Site Status

Hanyang University Guri Hospital

Guri-si, , South Korea

Site Status

CHA Bundang Medical Center CHA University

Seongnam-si, , South Korea

Site Status

Seoul National University Bundang Hospital

Seongnam-si, , South Korea

Site Status

Kyung Hee University Hospital

Seoul, , South Korea

Site Status

Kangbuk Samsung Hospital

Seoul, , South Korea

Site Status

Severance Hospital, Yonsei University Health System

Seoul, , South Korea

Site Status

Samsung Medical Center

Seoul, , South Korea

Site Status

Hospital del Mar

Barcelona, , Spain

Site Status

Hospital Clinic I Provincial de Barcelona

Barcelona, , Spain

Site Status

Hospital Universitario Puerta de Hierro Majadahonda

Majadahonda, , Spain

Site Status

Corporacion Sanitaria Parc Tauli

Sabadell, , Spain

Site Status

Hospital Universitario Miguel Servet

Zaragoza, , Spain

Site Status

Danderyds Sjukhus AB

Stockholm, , Sweden

Site Status

Crohn-Colitis Zentrum Bern Gemeinschaftspraxis Balsiger Seibold und Partner

Bern, , Switzerland

Site Status

Ankara University Medical Faculty

Ankara, , Turkey (Türkiye)

Site Status

Yeditepe University Medical School Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Istanbul University Cerrahpasa Medical Faculty Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Acibadem Fulya Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Haydarpasa Numune Training and Research Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Istanbul Medeniyet Uni Goztepe Training&Res Hosp

Istanbul, , Turkey (Türkiye)

Site Status

Marmara University Pendik Training and Research Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Ege University Medical Faculty

Izmir, , Turkey (Türkiye)

Site Status

Kocaeli Derince Training and Research Hospital

Kocaeli, , Turkey (Türkiye)

Site Status

RCI Chernivtsi Regional Clinical Hospital Dept of Surgery Bukovinian SMU

Chernivtsi, , Ukraine

Site Status

CI of PH Kharkiv CCH #2

Kharkiv, , Ukraine

Site Status

Treatment-Diagnostic Center of Private Enterprise of PMF Atsynus

Kirovohrad, , Ukraine

Site Status

Ukrainian-German Antiulcer Gastroenterological Center BYK-Kyiv LLC

Kyiv, , Ukraine

Site Status

Kyiv City Clinical Hospital #1

Kyiv, , Ukraine

Site Status

SI Republican Clinical Hospital of the MOHU Dept of Gastroenterology O.O.Bogomolets NMU

Kyiv, , Ukraine

Site Status

CI Odesa Regional Clinical Hospital

Odesa, , Ukraine

Site Status

Ternopil City Communal Emergency Medical Care Hospital

Ternopil, , Ukraine

Site Status

CI Zaporizhzhia Regional Clinical Hospital of ZRC

Zaporizhzhya, , Ukraine

Site Status

Royal Devon and Exeter Hospital Wonford

Exeter, , United Kingdom

Site Status

Queen Elizabeth University Hospital

Glasgow, , United Kingdom

Site Status

Glasgow Royal Infirmary

Glasgow, Scotland, , United Kingdom

Site Status

Hull Royal Infirmary

Hull, , United Kingdom

Site Status

Royal London Hospital

London, , United Kingdom

Site Status

St Marys Hospital

London, , United Kingdom

Site Status

Manchester Royal Infirmary

Manchester, , United Kingdom

Site Status

Nottingham University Hospitals Queens Medical Centre

Nottingham, , United Kingdom

Site Status

John Radcliffe Hospital

Oxford, , United Kingdom

Site Status

Royal Shrewsbury Hospital

Shrewsbury, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Austria Belgium Bulgaria Canada Croatia Czechia Denmark France Germany Greece Hungary Israel Italy Latvia Netherlands Norway Poland Portugal Romania Russia Serbia Slovakia South Korea Spain Sweden Switzerland Turkey (Türkiye) Ukraine United Kingdom

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GED-0301-CD-004

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Reduce Risk for Crohn's Disease Patients
NCT02852694 COMPLETED PHASE4
Open-Label Extension Study of GSK1605786A
NCT01318993 TERMINATED PHASE3